The Association of Independent Multiple Pharmacies (AIMp) and senior official of NHS Property Services (NHSPS) had a meeting on August 18 to review the rent
policy for health centre pharmacies.
Earlier, the association had sent a letter to NHSPS that was signed by pharmacies from across the sector, including single independents, pharmacy groups and members
of the Company Chemists' Association.
The letter outlined concerns about rent reviews and the impact of it on the co-located health centre pharmacies.
Dr Leyla Hannbeck, CEO of AIMp, said: "We outlined that whilst in the past, the norm established by the industry, was to base rents for co-located pharmacies
primarily based on patient list size, (and taking account of a few other factors), the industry now needs to revise the basis on which rents are determined for
co-located pharmacies."
The association, on behalf of the pharmacy sector, met the CEO of NHSPS and two of their senior directors (director or property management and their finance director).
It is no secret that hospitals and other healthcare facilities are breeding grounds for bacteria and viruses. In order to protect patients, it is essential
that medical staff maintain a high level of hygiene at all times. Unfortunately, many healthcare workers do not take the necessary precautions to keep themselves
clean. In this blog post, we will discuss some tips on how to increase the hygiene level of your medical staff. We will also touch on the importance of enforcing
strict hand-washing policies and wearing personal protective equipment (PPE).
1) THEY MUST WEAR SCRUB HATS
One of the most important things that you can do to increase the hygiene level of your medical staff is to make sure that they are wearing scrub hats. Scrub hats
help to keep hair out of patients' wounds and also prevent the spread of bacteria and viruses from the hair to the hands. While it is not mandatory for all medical
staff to wear scrub hats, it is strongly encouraged. Also, be sure to provide clean scrub hats for each shift.
The Royal Pharmaceutical Society (RPS) has appointed James Davies as Director of England.
Davies will be joining RPS in January 2023 to drive professional leadership for the pharmacy profession in England, working with and for RPS members.
He'll lead on national policy development, professional advocacy and member engagement across England, in partnership with the English Pharmacy Board.
Davies said: "It's a privilege to take up this position within the RPS, the professional home of pharmacy. I have been a member of the RPS throughout my pharmacy
career, and that has helped me to continually drive excellence in pharmacy practice. I'm excited about delivering the current RPS strategy to ensure that pharmacy
is, and continues to be, at the forefront of healthcare. I'm eager to work as part of the team and with the Board, leading and developing opportunities for the
profession that improve the lives of patients and the public.
Royal Pharmaceutical Society (RPS) and the Royal College of General Practitioners in Scotland hosted an event celebrating the collaborative work of the health
professions and policy makers in Scotland on reducing the environmental harm from prescribing and medicines use.
To share priorities for the Scottish Government, Alpana Mair, Head of Effective Therapeutics and Prescribing spoke and National Clinical Director Jason Leitch
appeared virtually. Gillian MacKay MSP, Scottish Greens spokesperson for Health and Social Care also joined in-person.
Medicines account for around 25% of the NHS's carbon emissions and have an ecological impact when they enter our wastewater system or our rivers and oceans.
Tackling the impact of prescribing will be a key part of meeting the ambition of a net zero NHS Scotland by 2040 at the latest.
Together, RCGP Scotland and RPS have held two roundtable events on sustainable prescribing, and in June 2022, released a joint statement calling for a wide range
of actions, which was signed by the Academy of Medical Royal Colleges and Faculties in Scotland, the Royal College of Physicians of Edinburgh, the Royal College of
Anaesthetists, the College of Radiographers, Royal College of Nursing, Queen's Nursing Institute Scotland and Chartered Society of Physiotherapy.
Continuing the work of RPS at the International Forum on Quality and Safety in Healthcare, the event aims to mark an opportunity for health professionals and
decision makers alike to join a global movement of sustainability in healthcare, and pledge to continue the important work of cutting the climate impact of medicine
use while maintaining the highest level of patient care and safety.
Community Pharmacy England (CPE) is aiming to reach an agreement with the Department of Health and Social Care (DHSC) and NHS England (NHSE) on negotiation
with regards to expanded services and payment model in the pharmacy sector.
Chief Executive Janet Morrison, said: "We are working at pace in negotiations with DHSC and NHSE. The process remains on track with the Government's original
timescale - i.e. aiming for agreement in July, with cross-government clearance later in July, and implementation from July through to September."
CPE is involved in working groups on service expansion of Hypertension Case-Finding and the Pharmacy Contraception Scheme and service design for the Common
Conditions Service; and are in in-depth negotiations on Payment models.
These discussions critically look at the balance between funding core capacity and activity payments, how the funding streams will be distributed and how CPE
will measure delivery and impact.
NHSE has been leading on the development of the PGD pathways for each of the 7 conditions, with external medical, pharmacy and other experts feeding into the
process - pharmacy owners from the Community Pharmacy England Committee have also been involved but the discussions are clinically led to ensure they comply with
NICE principles and concur with Antimicrobial Stewardship policy.
The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist
workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.
Welcoming its publication Alison Jones, PDA Director of Policy said: "It gives greater clarity around the future direction and strategy for professional development,
training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development
of the clinical role of pharmacists to support better patient care.
"However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire
life course.
Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are
regularly highlighted through activities, such as the safer pharmacies survey.
Walgreens Boots Alliance on Tuesday (June 28) scrapped the plan to sell its UK high street pharmacy chain saying no third party was able to make an adequate
offer due to the turmoil in global financial markets.
Walgreens' move to call off the sale comes as private equity bidders Apollo Global and TDR faced headwinds in raising financing for the deal, as banks were wary
of underwriting large chunks of the financing due to tough market conditions.
Boots was initially valued at as much as £8bn with the auction process being led by Goldman Sachs.
Global economic uncertainty and rising inflation have triggered a spike in interest rates as central banks have rushed to take action in the most widespread
tightening of monetary policy for more than two decades, making deal financing costlier and harder to access.
Walgreens had put its Boots UK business up for sale after announcing a strategic review in January as the second-largest US pharmacy chain renewed its focus on
domestic healthcare.
The company said the decision to retain Boots and No7 Beauty Company was also underpinned by their ongoing strong performance.
The National Pharmacy Association (NPA) has commissioned Professor David Taylor of University College London to investigate the implications of all-time high
inflation rates on community pharmacies in the UK.
Professor Taylor's will assess rates of inflation affecting community pharmacy across the UK, using public data sources whilst examining inflated costs in the
context of the current five year contractual framework in England (2019-2024).
He would review the EY (Ernst & Young) report into pharmacy funding, to identify whether current inflationary pressures could change any of the findings and
consider the policy implications and impacts of inflationary pressures, including pharmacy's ability to prepare for a more clinically focused future and maintain
current core services.
NPA chief executive Mark Lyonette said: "Inflationary pressures are eating into the limited funds provided by the NHS for pharmacy services. We believe the real
level of inflation for pharmacy businesses could be higher than the CPI inflation rate, which itself is at a 40 year high. Staff and locum costs in the sector as
well as medicines costs have risen dramatically.
The General Pharmaceutical Council (GPhC) has developed two new resources- Keeping patients safe being open and honest and Pharmacy team toolkit - learning
from incidents, to help pharmacists and pharmacy technicians fulfil the duty of candour - the professional responsibility to be open and honest with patients if/when
something goes wrong.
The new resources bring together relevant existing policy, standards, and previous statements on the professional obligations of pharmacists and pharmacy technicians,
with respect to candour.
It also emphasises that the duty of candour is not an add on - it's a fundamental part of pharmacy professional practice.
The responsibility to be open and honest applies even in difficult or challenging times and it's essential that professionals do the right thing for patients, their
families and carers. Saying sorry meaningfully when things go wrong is vital for everyone involved.
Given the link with issues around liability and indemnity, the National Pharmacy Association and the Pharmacists' Defence Association - as leading providers of
professional indemnity - have also contributed to the new resources and highlighted the importance of openness and transparency in this context.
All candidates in Great Britain who faced problems when sitting the General Pharmaceutical Council (GPhC)'s registration assessment will be eligible for
provisional registration, the pharmacy regulator has announced.
However, they are eligible only if they meet eligibility criteria set out in the GPhC policy which states: "Have sat the registration assessment on 29 June 2022
and experienced delays of 30 minutes or more in starting or completing either or both Part 1 and/or Part 2 of the registration assessment due to technical or other
IT difficulties (This also includes those who withdrew from the registration assessment on the day due to the start of the assessment being delayed by 30 minutes or
more)."
GPhC added that these candidates will also be able to claim a full refund, and this sitting will not count as one of their three attempts.
Gisela Abbam, chair of the GPhC, said: "We would like to sincerely apologise again to the candidates who experienced significant problems during their registration
assessment sitting.
The Taskforce report recognises the important role of community pharmacy and pharmacy teams, and in particular, the fact that they often have most contact with
individuals who are receiving medication assisted treatment, commented the Royal Pharmaceutical Society (RPS) on the publication of the Scottish Drug Deaths
Taskforce's final report.
The final report published on Thursday (June 21) follows four years of work developing and implementing a programme of actions to tackle the rising number of drug
deaths in Scotland.
RPS, as pharmacy's professional leadership body in Scotland and the rest of Great Britain, has positively engaged with the Taskforce as it carried out its work.
Last year, RPS published 'Pharmacy's role in reducing harm and preventing drugs deaths (Scotland)' which contained 14 key recommendations. Many of the recommended actions within the Taskforce's report align with RPS policy.
A new report published today (June 29) by the think tank Policy Exchange highlights key role for community pharmacy in management of primary-secondary care
interface.
The report called Medical Evolution has received cross-party support. It says an equivalent of 15 million GP appointments per year are spent dealing with issues
managing care between GP practices and hospitals.
Research from the think tank also finds 150,000 people could be on 'hidden' waiting lists (where a patient has been referred by a GP for further treatment, but
not included on official hospital waiting lists).
On the eve of the NHS Long Term Workforce Plan, the report calls for the development of 'interface specialists' - which could be undertaken by doctors, nurses or
community pharmacists to enable them to work more routinely across settings and to strategically plan interface working.
Community Pharmacy England (CPE) is organising a series of webinars to help pharmacy owners and their teams to prepare for the implementation of new
Pharmacy First service, and changes to the Contraception and Hypertension Case-Finding Services.
Beginning from 5th December, the webinars would be conducted throughout December and January, with support from NHS England and the Centre for Postgraduate
Education (CPPE), the organisation announced on Thursday (30 November).
During the online seminars, pharmacy teams will be explained about the individual services announced, and things to consider before they start providing, or
expand their offering of, these services.
Each webinar will have CPE's Services Team, who would be leading the team, and policy experts from NHS England and CPPE as speakers.
The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK Country Manager at Viatris, as its new Vice-Chair with immediate effect.
He will replace the current chair of the BGMA, Diane DiGangi-Trench, who is the UK country head for Sandoz.
Salzman, who is originally from Australia, has served approximately 1 billion patients worldwide last year as the UK Country Manager at Viatris, a global
pharmaceutical company operating in 165 countries.
In his role as BGMA Vice-Chair, Salzmann would focus on working in partnership with key stakeholders - the NHS, healthcare professionals, policy makers,
clinical societies, patient associations, academia - to ensure access to affordable and sustainable medicines for patients and the NHS.
Community pharmacy representatives and MPs from across all political parties discussed the impact of winter pressures on pharmacies in England during a
parliamentary drop-in event held on Tuesday (5 December).
As many as 34 MPs attended the event, including Bradford South MP Judith Cummins, who hosted the event.
Members of the Community Pharmacy England (CPE) Policy Team and LPC leaders briefed the politicians about the current winter pressures that all NHS community
pharmacies are grappling with, and asked them to help get more support.
CPE Chief Executive Janet Morrison said: "Community pharmacies play an active role to support their patients throughout the winter period, but the sector needs
fair and proper funding to enable its vital services to be delivered in the long term. This event came at a key moment for the sector as we work towards
implementing the Pharmacy First service and negotiations begin for the 2024/25 Community Pharmacy Contractual Framework (CPCF).
Laura Wilson, Director of the Royal Pharmaceutical Society (RPS) in Scotland discussed the future of the pharmacy workforce with Michael Matheson,
Cabinet Secretary for Health and Social Care at the SNP conference.
The event, which took place on 17 October in Aberdeen, Scotland featured other health officials including Colin Poolman, Director of the Royal College of
Nursing; Kenryck Lloyd-Jones, Public Affairs and Policy Manager for Scotland, Chartered Society of Physiotherapy; and Chris Marshall, Deputy Editor at Holyrood
Communications.
The Scottish government has recently unveiled its national workforce strategy for health and social care, laying out its plans for achieving recovery, growth,
and transformation.
Wilson highlighted the challenges and opportunities for the pharmacy workforce in Scotland to attract potential pharmacists into the profession and encourage
them to stay within the profession.
"This was a great opportunity to discuss with the Cabinet Secretary the challenges which exist for the pharmacy workforce in Scotland and to highlight some of
the solutions which need to be implemented to ensure a pharmacy workforce in Scotland which is fit for the future," she said.
Scottish community pharmacies will now hold two Naloxone kits, available in either nasal spray or injectable form, essential for reversing opioid overdoses.
The Emergency Access Naloxone Scheme, which is backed by £300,000 of Scottish Government funding, began on Monday (30 October).
Drugs and Alcohol Policy Minister Elena Whitham said, "Through our National Mission to reduce drug deaths and harms, we have invested more than £3 million in
widening access to Naloxone, including through our emergency services."
Witham said this new nationwide service is a welcome addition to existing services. "Police Scotland recently completed a force-wide rollout to 12,500 officers
who have used the kits more than 300 times. According to the most recent statistics, 70 per cent of those who are at risk of opioid overdose are being provided
with a lifesaving kit," she added.
"It provides a substantial increase in life-saving emergency access and I'm grateful to all those in community pharmacies who are supporting our £250 million
National Mission to reduce drug deaths," Whitham said.
As the countdown to the next UK election begins, the King's Fund has identified three priorities to improve public health.
The national action would be taken by the future government to fix the "NHS and social care" in the country.
The health policy think tank said it would prioritise "improving access to out-of-hospital care", making "careers in health and social care" more attractive
and tackling the biggest risk factors affecting people's health.
It highlighted that workforce crisis is one of the biggest challenges faced by the National Health Service (NHS) and social care services in England while
citing "years of poor planning and fragmented responsibilities" as the reason for widespread staff shortages.
As per the King's Fund's data, there were more than 125,000 vacancies across the NHS workforce in England in October 2023, not including primary care vacancies
such as GPs, and 152,000 vacant posts in the adult social care workforce.
Pharmacists globally are broadening their roles to support self-care, aiming to enhance patient health outcomes through increased contributions and proactive
behaviours, according to a new report.
However, significant barriers, including inadequate funding and limited access to patient records, impede the optimisation of self-care activities and outcomes
improvement in this area, the International Pharmaceutical Federation (FIP) said in its report.
The FIP report, titled 'Community Pharmacy Insights: Supporting the Need for Self-Care,' gathers insights from 238 respondents across 55 countries with the aim
of providing evidence-based policy support for workforce development.
Nearly all respondents (93.2 per cent) indicated that pharmacists should actively engage in providing self-care support, FIP said. Furthermore, 48.9 per cent
supported the involvement of pharmacy technicians, while 39.2 per cent endorsed the participation of pharmacy assistants and other team members in offering
self-care support.
Royal Pharmaceutical Society (RPS) Scotland has submitted its evidence to the Health, Social Care and Sport Committee's inquiry into 'Healthcare in remote
and rural areas.'
The Committee had sought views on what policies and actions would be most effective in addressing the issues people face when accessing healthcare in these areas.
During the evidence session today (19 December), Laura Wilson, Director for RPS Scotland, highlighted the challenges faced by pharmacists and pharmacy in remote and
rural areas, as well as provided some of the solutions for ensuring a sustainable pharmacy workforce.
At present, people living in remote and rural areas of Scotland are required to travel to Glasgow or Aberdeen to undertake pharmacy training. Laura underscored the
need to develop alternative education and training pathways, such as "grow your own" models, to support remote and rural areas to develop and retain local pharmacists.